Double Duty: Creating Trials To Satisfy Both FDA And CMS
This article was originally published in The Gray Sheet
Executive Summary
Firms can do "double duty" by gathering economic data during their FDA pivotal trials to get a jump start on CMS coverage, according to Abbott Diagnostic's Barbara Calvert, director of medical products reimbursement